Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 11/16/2024, indicates that Shah does not beneficially own any securities in the company. The filing, which is a standard regulatory requirement for officers, directors, and 10% owners, provides transparency about the holdings of company insiders. Shah's filing was completed on 11/18/2024 and is part of the compliance with Section 16(a) of the Securities Exchange Act of 1934.